Dr. Gordon E Johns, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632 Fax: 360-807-7687 |
Dr. Rochelle Deanne Cochrane, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2517 Ne Kresky Avenue, Chehalis, WA 98532 Phone: 360-748-8632 Fax: 360-748-3869 |
Dr. Robert Orland Ford, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632 Fax: 360-748-3869 |
Dr. Paul Y Chung, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632 Fax: 360-748-3869 |
Ronald K Sugiyama, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632 |
Dr. Robert Marshall Ford, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632 Fax: 360-748-3869 |
Dr. Jason Leng, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632 Fax: 360-748-3869 |
Dr. David L Gano, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2517 Ne Kresky Ave, Chehalis, WA 98532 Phone: 360-748-8632 Fax: 360-807-7687 |
News Archive
Many non-vegan vegetarians and omnivores are open to including insects in their diet. For vegans, however, that is not an option, a new study from the University of Eastern Finland shows.
Heavy traffic corridors in the cities of Long Beach and Riverside are responsible for a significant proportion of preventable childhood asthma, and the true impact of air pollution and ship emissions on the disease has likely been underestimated, according to researchers at the University of Southern California (USC).
Canada is delivering on its commitment to help the world's most vulnerable, thanks to new developments which will provide an affordable, reliable, and stable treatment for malaria that will save millions of lives, especially those of women and children in Africa.
Bayer HealthCare today announced the company has started to enroll patients in an international Phase II/III trial to evaluate its investigational compound BAY94-9027 for the treatment of hemophilia A in children.
The Food and Drug Administration on Thursday said it planned to revoke a medical-device company's right to sell a knee implant called Menaflex after an unprecedented yearlong review concluded the agency erred in allowing it on the market
› Verified 7 days ago